Top Markets
Coin of the day
Cypherpunk Technologies Inc. Cypherpunk Technologies Inc.

Cypherpunk Technologies Inc.

CYPH
Peringkat dalam Saham #19170
Cypherpunk Technologies Inc. is a biopharmaceutical company dedicated to the... Cypherpunk Technologies Inc. is a biopharmaceutical company dedicated to the acquisition and development of antibody treatments for cancer. The firm's flagship investigational drug, DKN-01, is a monoclonal antibody designed to suppress Dickkopf-related protein 1 and is currently progressing through multiple clinical trials for various esophagogastric, gynecologic, and colorectal cancers. Additionally, the company is advancing FL-501, another monoclonal antibody that targets the GDF-15 protein, which is presently in preclinical development. Cypherpunk has established an agreement with Adimab, LLC and BeiGene, Ltd., granting it options and licenses to advance and market DKN-01 across Asia (excluding Japan), Australia, and New Zealand. Founded in 2011, the company operates from Cambridge, Massachusetts, and was formerly known as Leap Therapeutics, Inc. until its renaming in November 2025.
Harga Saham
$1.62
Terakhir disinkronkan: 2026-08-25
Kapitalisasi Pasar
$172.47M
Perubahan (1 hari)
-3.57%
Perubahan (1 tahun)
446.74%
Negara
US
Perdagangan Cypherpunk Technologies Inc. (CYPH)

Kategori

Riwayat harga saham Cypherpunk Technologies Inc. (CYPH)
Harga penutupan tertinggi: $0.94 pada 2026-08-01

Harga penutupan terendah: $75.65 pada 2017-01-01
Riwayat harga saham Cypherpunk Technologies Inc. dari 2017 hingga 2026
Performa harga saham tahunan
Tahun Performa
2026 (TTM) -31.92%
2025 -58.69%
2024 -5.41%
2023 -33.87%
2022 -82.32%
2021 38.52%
2020 121.83%
2019 -68.29%
2018 -56.56%
2017 0.00%
Harga saham perusahaan atau pesaing serupa
Perusahaan Harga saham Perubahan 1th% Negara
$553.09 42.85%
US
$1.02K 44.02%
NL
$158.64 541.49%
US
$121.62 -12.98%
AU
$770.45 7.08%
CH